4.4 Article

Association of heme-oxygenase 1, hemopexin, and heme levels with markers of disease severity in COVID-19

Related references

Note: Only part of the references are listed.
Article Hematology

Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19

Michael W. Henderson et al.

Summary: Activation of the contact and intrinsic pathways may contribute to the prothrombotic state in COVID-19, and FIXa:AT complexes may serve as a clinically useful biomarker of adverse clinical outcomes.

BLOOD ADVANCES (2022)

Article Medicine, Research & Experimental

Evaluation of the mechanisms of heme-induced tissue factor activation: Contribution of innate immune pathways

Bidossessi Wilfried Hounkpe et al.

Summary: Hemoglobin can induce the expression and activation of tissue factor, contributing to the pathogenesis of hypercoagulability in hemolytic diseases.

EXPERIMENTAL BIOLOGY AND MEDICINE (2022)

Article Biochemistry & Molecular Biology

Increase of HO-1 Expression in Critically Ill COVID-19 Patients Is Associated with Poor Prognosis and Outcome

Maria G. Detsika et al.

Summary: The increase in HO-1 expression observed in critically ill COVID-19 patients is associated with disease progression and poor outcome. The upregulation of HO-1 in blood and tissues of severe patients may serve as a protective mechanism against coagulation and thrombosis.

ANTIOXIDANTS (2022)

Article Multidisciplinary Sciences

Heme oxygenase-1 as an important predictor of the severity of COVID-19

Yu Hara et al.

Summary: This study found that serum HO-1 can serve as a predictive biomarker for assessing disease severity and prognosis in COVID-19 patients. Serum HO-1 correlates with other clinical parameters and outcomes.

PLOS ONE (2022)

Article Virology

Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin-Kallikrein System in Severe COVID-19

Eli Mansour et al.

Summary: The study found that the pharmacological inhibition of the kinin-kallikrein system with icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19 patients, while not affecting the time to clinical improvement, was safe and effective in promoting significant improvement in lung computed tomography scores and increased blood eosinophils, indicating improved disease recovery.

VIRUSES-BASEL (2021)

Article Oncology

Is haem the real target of COVID-19?

Valentina Rapozzi et al.

Summary: Despite the launch of vaccination campaigns, the emergence of new variants of the COVID-19 virus has raised concerns, emphasizing the importance of finding ways to prevent or reduce its virulence and pathogenicity. The virus interacts with hemoglobin, inducing hemolysis and potentially disrupting miRNA processing, which could impede the antiviral response. Understanding these mechanisms is crucial in effectively combating the ongoing pandemic.

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2021)

Article Immunology

Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

Aldo Bonaventura et al.

Summary: The authors suggest that SARS-CoV-2 infection induces a prothrombotic state and dysregulated immunothrombosis, leading to severe manifestations of COVID-19. They also discuss potential antithrombotic and immunomodulating drugs for treating COVID-19 patients, aiming to reduce the acute and long-term consequences of the disease by targeting immunothrombosis.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Immunology

Regulation of inflammation by the antioxidant haem oxygenase 1

Nicole K. Campbell et al.

Summary: HO-1, known for its antioxidant properties, has also been shown to have anti-inflammatory effects, making it a potential treatment for chronic inflammatory and autoimmune diseases. Inducing HO-1 has therapeutic potential, but there are challenges to translating this treatment to clinical use.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Hematology

Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses

Nigel Mackman et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Article Hematology

No evidence of hemoglobin damage by SARS-CoV-2 infection

Anthony W. DeMartino et al.

HAEMATOLOGICA (2020)

Article Immunology

Desaturation and heme elevation during COVID-19 infection: a potential prognostic factor of heme oxygenase-1

Wen-Lin Su et al.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)

Article Biochemistry & Molecular Biology

Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications

Devendra Singh et al.

FREE RADICAL BIOLOGY AND MEDICINE (2020)

Article Chemistry, Medicinal

Heme/Hemeoxygenase-1 System Is a Potential Therapeutic Intervention for COVID-19 Patients with Severe Complications

Biplab K. Maiti

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)

Article Hematology

Circulating Heme Oxygenase-1 and Complement Activation in Transplant-Associated Thrombotic Microangiopathy

Tingting Pan et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

Review Cell Biology

Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Zewen Liu et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)

Article Multidisciplinary Sciences

Tissue factor-dependent coagulation activation by heme: A thromboelastometry study

Gleice Regina de Souza et al.

PLOS ONE (2017)

Review Pathology

Modulation of Antiviral Immunity by Heme Oxygenase-1

Janyra A. Espinoza et al.

AMERICAN JOURNAL OF PATHOLOGY (2017)

Article Multidisciplinary Sciences

Human heme oxygenase 1 is a potential host cell factor against dengue virus replication

Chin-Kai Tseng et al.

SCIENTIFIC REPORTS (2016)

Review Cardiac & Cardiovascular Systems

Haeme oxygenase signalling pathway: implications for cardiovascular disease

Laura E. Fredenburgh et al.

EUROPEAN HEART JOURNAL (2015)

Article Hematology

Excess of heme induces tissue factor-dependent activation of coagulation in mice

Erica M. Sparkenbaugh et al.

HAEMATOLOGICA (2015)

Article Hematology

Excess of heme induces tissue factor-dependent activation of coagulation in mice

Erica M. Sparkenbaugh et al.

HAEMATOLOGICA (2015)

Review Biochemistry & Molecular Biology

New Insights into Intracellular Locations and Functions of Heme Oxygenase-1

Louise L. Dunn et al.

ANTIOXIDANTS & REDOX SIGNALING (2014)

Article Virology

The Cytoprotective Enzyme Heme Oxygenase-1 Suppresses Ebola Virus Replication

Lindsay Hill-Batorski et al.

JOURNAL OF VIROLOGY (2013)

Article Biochemistry & Molecular Biology

Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice

Nathan W. Cummins et al.

FASEB JOURNAL (2012)

Article Oncology

Human Heme Oxygenase-1 Deficiency Presenting With Hemolysis, Nephritis, and Asplenia

Nita Radhakrishnan et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2011)

Review Biochemistry & Molecular Biology

Heme Scavenging and the Other Facets of Hemopexin

Emanuela Tolosano et al.

ANTIOXIDANTS & REDOX SIGNALING (2010)

Article Biology

Candidate Genes Associated with Susceptibility for SARS-Coronavirus

Ying-Hen Hsieh et al.

BULLETIN OF MATHEMATICAL BIOLOGY (2010)

Review Biochemistry & Molecular Biology

Heme oxygenase-1: from biology to therapeutic potential

Miguel P. Soares et al.

TRENDS IN MOLECULAR MEDICINE (2009)

Article Pathology

Induction of Heme Oxygenase-1 Is a Beneficial Response in a Murine Model of Venous Thrombosis

Michal J. Tracz et al.

AMERICAN JOURNAL OF PATHOLOGY (2008)

Article Pathology

Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease

KA Nath et al.

AMERICAN JOURNAL OF PATHOLOGY (2001)